Immune Checkpoint Inhibitors in Advanced NSCLC: [
IrAEs
NSCLC
PD-1
[18F]FDG PET/CT
immunotherapy
treatment response
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
15 Sep 2021
15 Sep 2021
Historique:
received:
23
07
2021
revised:
02
09
2021
accepted:
11
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The aim of this study was to investigate whether [ Twenty-eight patients who underwent [ The CD was achieved in 54% of patients. Out of 28 eligible patients, 13 (46%) experienced progressive disease (PD), 7 showed SD, 7 had PR, and only in one patient CR was achieved. ΔSUV [
Identifiants
pubmed: 34574022
pii: diagnostics11091681
doi: 10.3390/diagnostics11091681
pmc: PMC8471751
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancer Commun (Lond). 2021 Apr;41(4):287-302
pubmed: 33689225
Int J Mol Sci. 2017 Sep 09;18(9):
pubmed: 28891933
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32709713
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380754
Lung Cancer. 2018 Jan;115:71-74
pubmed: 29290265
Cancers (Basel). 2021 Apr 01;13(7):
pubmed: 33915801
Eur J Cancer. 2016 Jul;62:132-7
pubmed: 27189322
Cancers (Basel). 2020 May 21;12(5):
pubmed: 32455666
Melanoma Res. 2019 Apr;29(2):178-186
pubmed: 30653029
Clin Lung Cancer. 2019 May;20(3):201-207
pubmed: 30442524
J Thorac Dis. 2019 Nov;11(11):E221-E223
pubmed: 31903287
Sci Rep. 2019 Sep 16;9(1):13362
pubmed: 31527660
Curr Radiopharm. 2020;13(3):177-184
pubmed: 31858908
Cancer Biother Radiopharm. 2021 Mar;36(2):123-132
pubmed: 32551915
Int J Clin Oncol. 2018 Dec;23(6):1052-1059
pubmed: 29948239
Nucl Med Commun. 2019 Aug;40(8):802-807
pubmed: 31045745
Cancer Lett. 2021 Nov 1;520:91-99
pubmed: 34237407
Radiographics. 2021 Jan-Feb;41(1):120-143
pubmed: 33275541
Cytokine. 2021 Feb;138:155363
pubmed: 33264749
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1019-1021
pubmed: 31996974
Molecules. 2021 Apr 11;26(8):
pubmed: 33920423
Diagnostics (Basel). 2017 Feb 15;7(1):
pubmed: 28212290
Rheumatology (Oxford). 2019 Dec 1;58(Suppl 7):vii59-vii67
pubmed: 31816080
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1072-1075
pubmed: 29532102
Clin Nucl Med. 2019 Apr;44(4):e272-e279
pubmed: 30688730
J Pers Med. 2021 Mar 18;11(3):
pubmed: 33803667
Cancer Med. 2017 Nov;6(11):2552-2561
pubmed: 28980429
JAMA Oncol. 2018 Mar 1;4(3):374-378
pubmed: 28975219
Transl Lung Cancer Res. 2015 Oct;4(5):560-75
pubmed: 26629425